Get my own profile
Public access
View all59 articles
40 articles
available
not available
Based on funding mandates
Co-authors
- M. Laird ForrestUniversity of KansasVerified email at ku.edu
- Shaofeng DuanResearch Associate of Pharmaceutical Chemistry at University of KansasVerified email at ku.edu
- Min PiGPRC6A, CASR, FGF23, dictyosteliumVerified email at uthsc.edu
- LD QuarlesUTHSCVerified email at uthsc.edu
- Qi ChenUniversity of Kansas Medial CenterVerified email at kumc.edu
- Cory BerklandWashington University in Saint LouisVerified email at wustl.edu
- Q. Sang, QX. Amy Sang (Qing-Xiang A...Florida State University, Department of Chemistry & BiochemistryVerified email at chem.fsu.edu
- Vaqar Mustafa AdhamiResearch Administrator at University of Wisconsin-MadisonVerified email at wisc.edu
- qing zhuUniversity of Kansas Medical CenterVerified email at kumc.edu
- Wanyi TaiSchool of Pharmaceutical Sciences,Wuhan University,ChinaVerified email at whu.edu.cn
- Jiazhi SunUniversity of South FloridaVerified email at health.usf.edu
- Neal DaviesDean of PharmacyVerified email at ualberta.ca
- Long-Cheng Li (李龙承)President & CEO, Ractigen Therapeutics & Adj Prof, Nantong UniversityVerified email at ractigen.com
- Prof. Chang-Bai Liu, MD. & PhD.Hubei Province Key Lab of Tumor Microenvironment and Immunotherapy, China Three Gorges UniversityVerified email at ctgu.edu.cn
- Jie DuCapital Medical University, Beijing Anzhen Hospital, Beijing Institue of Heart, Lung and BloodVerified email at ccmu.edu.cn
- Patrick RaynalINSERM Research director (DR2), CERPPS (UT2), TMBI (Univ. Toulouse)Verified email at inserm.fr